Publication:
Multiple Sclerosis Severity Score (MSSS) Helps Predict Relapses and Recovery from Disability in Patients Treated for Multiple Sclerosis in the MSBase Model

dc.contributor.authorKister, I.
dc.contributor.authorBacon, T. E.
dc.contributor.authorMalpas, C. B.
dc.contributor.authorSharmin, S.
dc.contributor.authorHorakova, D.
dc.contributor.authorHavrdova, E. K.
dc.contributor.authorSa, M. J.
dc.contributor.authorIDTurkoglu, Recai/0000-0001-9724-851X
dc.contributor.authorIDFerraro, Diana/0000-0003-4818-3806
dc.date.accessioned2020-06-21T12:25:59Z
dc.date.available2020-06-21T12:25:59Z
dc.date.issued2019
dc.departmentOMÜen_US
dc.department-temp[Kister, I. -- Bacon, T. E.] NYU, Sch Med, Neurol, New York, NY USA -- [Malpas, C. B. -- Sharmin, S.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia -- [Horakova, D. -- Havrdova, E. K.] Charles Univ Prague, Dept Neurol, Prague, Czech Republic -- [Patti, F.] Univ Catania, GF Ingrassia Dept, Catania, Italyen_US
dc.description35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS -- SEP 11-13, 2019 -- Stockholm, SWEDENen_US
dc.description.abstracten_US
dc.description.sponsorshipEuropean Comm Treatment & Res Multiple Sclerosis, Congrex Switzerland Ltden_US
dc.description.sponsorshipBiogenBiogen; Czech Minsitry of Education [Q27/LF1]en_US
dc.description.sponsorshipDana Horakova received speaker honoraria and consulting fees from Biogen, Merck, Teva, Roche, Sanofi Genzyme, and Novartis, as well as support for research activities from Biogen and Czech Minsitry of Education [project Progres Q27/LF1].; Eva Kubala Havrdova received speaker honoraria and consultant fees from Actelion, Biogen, Celgene, Merck, Novartis, Roche, Sanofi and Teva, and support for research activities from Czech Ministry of Education [project Progres Q27/LF1].en_US
dc.identifier.endpage188en_US
dc.identifier.issn1352-4585
dc.identifier.issn1477-0970
dc.identifier.startpage186en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/10619
dc.identifier.volume25en_US
dc.identifier.wosWOS:000485303100308
dc.language.isoenen_US
dc.publisherSage Publications Ltden_US
dc.relation.journalMultiple Sclerosis Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleMultiple Sclerosis Severity Score (MSSS) Helps Predict Relapses and Recovery from Disability in Patients Treated for Multiple Sclerosis in the MSBase Modelen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files